BioCentury
ARTICLE | Company News

Pfenex, National Institutes of Health, U.S. Department of Health and Human Services infectious, drug delivery news

October 22, 2012 7:00 AM UTC

NIH's National Institute of Allergy and Infectious Diseases (NIAID) awarded Pfenex a contract worth up to $22.9 million for up to five years to develop a dry formulation of its recombinant protective ...